Ignite Creation Date:
2024-05-06 @ 4:01 AM
Last Modification Date:
2024-10-26 @ 11:42 AM
Study NCT ID:
NCT02437318
Status:
COMPLETED
Last Update Posted:
2023-11-18
First Post:
2015-04-22
Brief Title:
Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-07-23
Start Date Type:
ACTUAL
Primary Completion Date:
2018-06-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-22
First Submit QC Date:
May 4 2015
Study First Post Date:
2015-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2019-08-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2018-07-24
Disp First Submit QC Date:
July 24 2018
Disp First Post Date:
2018-07-26
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-11-17
Last Update Post Date:
2023-11-18
Last Update Post Date Type:
ACTUAL